• Sun. Feb 28th, 2021

Dimancherouge

Technology

Oral Anti-Diabetic Drugs Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2024

The MarketWatch News Department was not involved in the creation of this content.

Sep 18, 2020 (AmericaNewsHour) —
Executive Summary

The Oral anti diabetes drug was valued at USD 25.6 Billion in the year 2018. Over the recent years, oral anti-diabetes drug has been witnessing considerable growth on the back of rising incidences of diabetes, growing geriatric population, growing government initiatives, and continuous research and development conducted by pharmaceutical manufacturers. In addition, growing sedentary lifestyle, presence of diabetes medicines in the Essential drug List of the nations and wide insurance coverage for diabetes drugs have contributed to the growth rate of Oral anti-diabetes drugs. These factors are anticipated to provide higher momentum to the market growth in the forecast period. However, preferred use of insulin over oral anti diabetes drugs and the complications associated with the drugs has been hindering the market growth.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10163646

Among all the types of oral anti-diabetes drugs that includes Biguanides, Sulfonylurease, DPP-4 inhibitor, SGL2 inhibitor and Thiazolidinedione, Biguanides holds the highest market share in the Oral Anti-diabetic drug Market owing to its proven benefits in the treatment of diabetes mellitus.

Among the regions, North America Oral Anti-diabetic drug Market will continue to be the largest market in the forecast period, majorly driven by favourable government reimbursement policies in addition to high healthcare awareness. Countries such as India, China, Brazil are a lucrative market for Oral Anti-diabetic drugs Market.

Scope of the Report

Global Oral Anti-Diabetes Drugs Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
? Oral Anti-Diabetes Drugs Market – Size, Growth, Forecast
? Analysis by Type: Biguanides, Sulfonylurease, DPP-4 inhibitor, SGL2 inhibitor, Thiazolidinediones, Others

Regional Oral Anti-Diabetes Drugs Market – North America, Europe, APAC, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
? Oral Anti-Diabetes Drugs Market – Size, Growth, Forecast
? Analysis by Type: Biguanides, Sulfonylurease, DPP-4 inhibitor, SGL2 inhibitor, Thiazolidinediones, Others

Country Analysis – U.S. Canada, U.K., Germany, France, Italy, India, Japan, China, Brazil (Actual Period: 2014-2018, Forecast Period: 2019-2024)
? Oral Anti-Diabetes Drugs Market – Size, Growth, Forecast
? Analysis by Type: Biguanides, Sulfonylurease, DPP-4 inhibitor, SGL2 inhibitor, Thiazolidinediones, Others

Company Analysis – Novartis, Pfizer, Sanofi, Merck & Co., AstraZeneca, Janssen Pharmaceutical, Boehringer Ingelheim, Eli Lilly, Takeda Pharmaceutical.

Other Report Highlights
? Competitive Landscape – Sales, Segments, Market Share
? Leading Companies
? Non generic drug analysis
? Market Dynamics – Drivers and Restraints.
? Market Trends
? Porter Five Forces Analysis.
? SWOT Analysis.

Request For Full Report: https://www.kennethresearch.com/sample-request-10163646

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:  [email protected]

Phone: +1 313 462 0609

The post Oral Anti-Diabetic Drugs Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2024 appeared first on America News Hour.

COMTEX_371482333/2606/2020-09-18T05:03:45

Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article